MVK: A Protein Target for Cancer and Other Diseases (G4598)

Target Name: MVK

NCBI ID: G4598

Content of Review Report on MVK Target / Biomarker

MVK

MVK: A Protein Target for Cancer and Other Diseases

MVK (LRBP), short for microvascular kinase, is a protein that is expressed in various tissues throughout the body. It is a key regulator of blood vessel growth and development, and is involved in the formation of new blood vessels, as well as the regulation of existing blood vessels. MVK has also been shown to play a role in the development and progression of various diseases, including cancer.

One of the key features of MVK is its ability to stimulate the growth of blood vessels. This is accomplished through the activation of several different signaling pathways, including the TGF-β pathway and the Src/FAK pathway. These signaling pathways involve the activation of several different proteins, including TGF-β, which is a transcription factor that regulates cell growth and differentiation.

In addition to its role in blood vessel growth and development, MVK has also been shown to play a key role in the regulation of cell signaling pathways. For example, MVK has been shown to interact with several different proteins, including the protein kinase FAK. This interaction between MVK and FAK has been shown to play a role in the regulation of cell signaling pathways, including the regulation of cell growth, differentiation, and survival.

MVK has also been shown to play a role in the development and progression of various diseases, including cancer. For example, MVK has been shown to be involved in the development of neurobladder cancer, a type of cancer that arises from the neurobladder, a gland that produces and transmits urine. MVK has also been shown to be involved in the development of liver cancer, a type of cancer that arises from the liver cells.

Given its role in cell signaling pathways and its involvement in the development and progression of various diseases, MVK is a promising drug target. Researchers are currently working to develop new treatments for MVK-related diseases, including cancer. These treatments are based on the use of small molecules, such as inhibitors of MVK, to selectively target MVK and prevent it from interacting with other proteins.

In conclusion, MVK is a protein that plays a key role in cell signaling pathways and is involved in the development and progression of various diseases. Its ability to stimulate blood vessel growth and development, as well as its role in the regulation of cell signaling pathways , make it an attractive drug target for the development of new treatments for MVK-related diseases. Further research is needed to fully understand the mechanisms of MVK and to develop effective treatments for MVK-related diseases.

Protein Name: Mevalonate Kinase

Functions: Catalyzes the phosphorylation of mevalonate to mevalonate 5-phosphate, a key step in isoprenoid and cholesterol biosynthesis (PubMed:9325256, PubMed:18302342, PubMed:9392419, PubMed:11278915)

The "MVK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MVK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets